Bio-Rad Laboratories, Inc. BIO.B Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s valuation allowance, deferred tax asset, increase (decrease), amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s valuation allowance, deferred tax asset, increase (decrease), amount?
- Bio-Rad Laboratories, Inc. (BIO.B) reported valuation allowance, deferred tax asset, increase (decrease), amount of $8.8M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s valuation allowance, deferred tax asset, increase (decrease), amount changed year-over-year?
- Bio-Rad Laboratories, Inc.'s valuation allowance, deferred tax asset, increase (decrease), amount increased by 29.4% year-over-year, from $6.8M to $8.8M.